CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Wall Street Zen
Wall Street Zen assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and set a $4.00 price objective on shares of CASI Pharmaceuticals in a research report […]
Wall Street Zen assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and set a $4.00 price objective on shares of CASI Pharmaceuticals in a research report […]
